consumer

Discussion in 'GlaxoSmithKline' started by anonymous, Sep 5, 2016 at 11:26 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    so many changes in category and markets. What's next?
     

  2. anonymous

    anonymous Guest

    When everything is going great, you change things up to be ahead of the curve. Emma is going to make a great CEO. #volumestrategy
     
  3. anonymous

    anonymous Guest

    so what other changes do you foresee? Categories are a mess! CL already talking about his next role. Do you really think Emma will get big job?
     
  4. anonymous

    anonymous Guest

    Emma as CEO? Ha ha ha ha ha.
     
  5. anonymous

    anonymous Guest

    Who is laughing now? Time to shape up pharma the way she did consumer. Goodbye bureaucracy, time for aggressive change and growth. She is our consumer rock star and she'll show you how to build a real pharma business.
     
  6. anonymous

    anonymous Guest

    Great hire! A toothpaste broad with no RX experience. Sounds like just what the company needed. Seriously, this is what they come up with? But at least she's a Brit. GSK will trumpet diversity as the stock retreats into the 30's. Break it up Enema and maybe I'll change my mind about this disaster.
     
  7. anonymous

    anonymous Guest



    How dare you call her a toothpaste broad........ she is a cosmetics broad.
     
  8. anonymous

    anonymous Guest

    Purrrrrfect for cover ups.

    The cat is black on a pillow.
     
  9. anonymous

    anonymous Guest

    L'Oreal: Perfect for Cover Ups!
     
  10. anonymous

    anonymous Guest

    Emma comes in with instant credibility. GSK sensodyne sales were £78M globally last year, up 4% yoy.
     
  11. anonymous

    anonymous Guest

     
  12. anonymous

    anonymous Guest



    And that blip noise was the drop falling into the bucket.
     
  13. sirandy

    sirandy new user

    Joined:
    Feb 13, 2016
    Messages:
    111
    Likes Received:
    1
    So, about the same amount as Dimwitty's payout. I think he should get a 4 rating for this year.

    Only GSK can disappoint the street with a new CEO announcement given how much they were looking forward to the end of the Twitty era. And yet, GSK even managed to screw this one up as well.

    Hello $40/share.
     
  14. anonymous

    anonymous Guest

    Bring on the merger
     
  15. anonymous

    anonymous Guest

    Pathetic appointment. Brings nothing to the major earnings and profit group of the company, which continues to be Pharma. Company has lost it's way due to poor UK centric management and won't change under this new CEO.
     
  16. anonymous

    anonymous Guest

    Thank you Warren Buffet ! Whatta' loser.
     
  17. anonymous

    anonymous Guest

    Emma will be great. Let's stop kidding ourselves about the Pharma business, it's not that difficult. It's about Leadership, Innovation and Business Management. Emma has a proven track record.
     
  18. anonymous

    anonymous Guest

    The pharma business is about innovative drug discovery and development. Novel drugs get formulary access and create value. Another insider from consumer is going get the same results as twit the sales rep.
     
  19. anonymous

    anonymous Guest

    New Volume Strategy
    [​IMG]
     
  20. anonymous

    anonymous Guest

    Hi Respiratory Rep here. I'm studying the training pack sent to me about our toothpaste franchise. Anyone interested in starting up a study group? Any Aquafresh reps out there that can go over the key messages?